Top stablecoin firm Tether is joining forces with one of the winningest football clubs in the world. According to a new ...

Republican Vivek Ramaswamy is preparing to launch his 2026 bid for Ohio governor on Feb. 24 in his native Cincinnati, with ...

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

An Albuquerque-based firm is taking its first steps into a potentially game-changing partnership through an SBIR Phase I ...

Bambusa Therapeutics has raised about $90 million to build out a pipeline of next-gen bispecific antibodies targeting ...

The company is now expecting 2025 revenue to range from $1.5 billion to $2.5 billion, with a midpoint of $2.0 billion, while FactSet is expecting $2.4 billion. Most of that will come in the second ...

Corbus Pharmaceuticals has posted the first Western clinical data on its would-be rival to Pfizer’s Padcev. The overall ...

Moderna Inc.'s stock fell 2.9% early Friday, after the biotech posted a wider-than-expected fourth-quarter loss and offered soft guidance for 2025, offsetting a revenue beat.

Thomas Jefferson Independent Day School will hold its spring fundraising event — called “Escapade: Party-Gras!” — at 5:30 p.m. Saturday, March 8. Alumni, family and the community are invited to attend ...

The syndicate led by Morgan Stanley, Goldman Sachs, JP Morgan and Evercore closed the books north of 20x covered on the back of strong long-only/mutual fund demand and a 100% hit rate in investor ...

Rare diseases have become an attractive target for pharmaceutical companies both on the ASX and internationally. ... Read ...

The 80-year-old partnership between the federal government and research institutions has made the U.S. the leader in ...